Enzon Inc Eastman Kodak Co's Eastman Pharmaceuticals division Food Drug Administration approve application allow clinical test PEG-uricase drug proceed. Kodak own 18.7 pct Enzon own marketing right PEG-uricase drug Enzon developing. The company PEG-uricase intend reduce uric acid level patient undergo chemotherapy suffer gout. A build uric acid bloodstream common effect chemotherapy lead kidney failure. Enzon FDA's rule allow patient life-threatening disease investigational drug uric acid level extremely ill patient decrease normal level 48 hour drug injected. Separately FDA grant permission include unlimited patient trial PEG-ADA drug treat rare usually fatal disease child call severe combine immuodeficiency. It five child treat drug hope file drug application PEG-ADA late 1987. When NDA approve drug marketed. Reuter 